Literature DB >> 17098869

Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria.

Jerome S Pinkner1, Han Remaut, Floris Buelens, Eric Miller, Veronica Aberg, Nils Pemberton, Mattias Hedenström, Andreas Larsson, Patrick Seed, Gabriel Waksman, Scott J Hultgren, Fredrik Almqvist.   

Abstract

A chemical synthesis platform with broad applications and flexibility was rationally designed to inhibit biogenesis of adhesive pili assembled by the chaperone-usher pathway in Gram-negative pathogens. The activity of a family of bicyclic 2-pyridones, termed pilicides, was evaluated in two different pilus biogenesis systems in uropathogenic Escherichia coli. Hemagglutination mediated by either type 1 or P pili, adherence to bladder cells, and biofilm formation mediated by type 1 pili were all reduced by approximately 90% in laboratory and clinical E. coli strains. The structure of the pilicide bound to the P pilus chaperone PapD revealed that the pilicide bound to the surface of the chaperone known to interact with the usher, the outer-membrane assembly platform where pili are assembled. Point mutations in the pilicide-binding site dramatically reduced pilus formation but did not block the ability of PapD to bind subunits and mediate their folding. Surface plasmon resonance experiments confirmed that the pilicide interfered with the binding of chaperone-subunit complexes to the usher. These pilicides thus target key virulence factors in pathogenic bacteria and represent a promising proof of concept for developing drugs that function by targeting virulence factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098869      PMCID: PMC1693844          DOI: 10.1073/pnas.0606795103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Structural basis of chaperone function and pilus biogenesis.

Authors:  F G Sauer; K Fütterer; J S Pinkner; K W Dodson; S J Hultgren; G Waksman
Journal:  Science       Date:  1999-08-13       Impact factor: 47.728

2.  X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli.

Authors:  D Choudhury; A Thompson; V Stojanoff; S Langermann; J Pinkner; S J Hultgren; S D Knight
Journal:  Science       Date:  1999-08-13       Impact factor: 47.728

3.  PapD-like chaperones provide the missing information for folding of pilin proteins.

Authors:  M M Barnhart; J S Pinkner; G E Soto; F G Sauer; S Langermann; G Waksman; C Frieden; S J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

4.  Design and evaluation of pilicides: potential novel antibacterial agents directed against uropathogenic Escherichia coli.

Authors:  A Svensson; A Larsson; H Emtenäs; M Hedenström; T Fex; S J Hultgren; J S Pinkner; F Almqvist; J Kihlberg
Journal:  Chembiochem       Date:  2001-12-03       Impact factor: 3.164

5.  Chaperone priming of pilus subunits facilitates a topological transition that drives fiber formation.

Authors:  Frederic G Sauer; Jerome S Pinkner; Gabriel Waksman; Scott J Hultgren
Journal:  Cell       Date:  2002-11-15       Impact factor: 41.582

6.  Bacterial outer membrane ushers contain distinct targeting and assembly domains for pilus biogenesis.

Authors:  David G Thanassi; Christos Stathopoulos; Karen Dodson; Dominik Geiger; Scott J Hultgren
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

7.  Structural basis of the interaction of the pyelonephritic E. coli adhesin to its human kidney receptor.

Authors:  K W Dodson; J S Pinkner; T Rose; G Magnusson; S J Hultgren; G Waksman
Journal:  Cell       Date:  2001-06-15       Impact factor: 41.582

8.  Type 1 pilus-mediated bacterial invasion of bladder epithelial cells.

Authors:  J J Martinez; M A Mulvey; J D Schilling; J S Pinkner; S J Hultgren
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

9.  An enantioselective ketene-imine cycloaddition method for synthesis of substituted ring-fused 2-pyridinones.

Authors:  H Emtenäs; L Alderin; F Almqvist
Journal:  J Org Chem       Date:  2001-10-05       Impact factor: 4.354

10.  Design and parallel solid-phase synthesis of ring-fused 2-pyridinones that target pilus biogenesis in pathogenic bacteria.

Authors:  Hans Emtenäs; Kristoffer Ahlin; Jerome S Pinkner; Scott J Hultgren; Fredrik Almqvist
Journal:  J Comb Chem       Date:  2002 Nov-Dec
View more
  104 in total

1.  Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Corinne K Cusumano; Thomas J Hannan; James W Janetka; Scott J Hultgren
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

Review 2.  Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.

Authors:  David G Thanassi; James B Bliska; Peter J Christie
Journal:  FEMS Microbiol Rev       Date:  2012-05-24       Impact factor: 16.408

3.  Design and synthesis of C-2 substituted thiazolo and dihydrothiazolo ring-fused 2-pyridones: pilicides with increased antivirulence activity.

Authors:  Erik Chorell; Jerome S Pinkner; Gilles Phan; Sofie Edvinsson; Floris Buelens; Han Remaut; Gabriel Waksman; Scott J Hultgren; Fredrik Almqvist
Journal:  J Med Chem       Date:  2010-08-12       Impact factor: 7.446

Review 4.  Structure, Function, and Assembly of Adhesive Organelles by Uropathogenic Bacteria.

Authors:  Peter Chahales; David G Thanassi
Journal:  Microbiol Spectr       Date:  2015-10

Review 5.  The emerging threat of multidrug-resistant Gram-negative bacteria in urology.

Authors:  Hosam M Zowawi; Patrick N A Harris; Matthew J Roberts; Paul A Tambyah; Mark A Schembri; M Diletta Pezzani; Deborah A Williamson; David L Paterson
Journal:  Nat Rev Urol       Date:  2015-09-01       Impact factor: 14.432

Review 6.  The biology and future prospects of antivirulence therapies.

Authors:  Lynette Cegelski; Garland R Marshall; Gary R Eldridge; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2008-01       Impact factor: 60.633

7.  Profile of Scott J. Hultgren.

Authors:  Nicholette Zeliadt
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-04       Impact factor: 11.205

Review 8.  A review on anti-adhesion therapies of bacterial diseases.

Authors:  Arezoo Asadi; Shabnam Razavi; Malihe Talebi; Mehrdad Gholami
Journal:  Infection       Date:  2018-10-01       Impact factor: 3.553

Review 9.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

10.  Nitazoxanide inhibits biofilm production and hemagglutination by enteroaggregative Escherichia coli strains by blocking assembly of AafA fimbriae.

Authors:  Eliah R Shamir; Michelle Warthan; Sareena P Brown; James P Nataro; Richard L Guerrant; Paul S Hoffman
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.